相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy
Richard Savdie et al.
BJU INTERNATIONAL (2012)
The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial
Maria Franlund et al.
BJU INTERNATIONAL (2012)
ESUR prostate MR guidelines 2012
Jelle O. Barentsz et al.
EUROPEAN RADIOLOGY (2012)
Three-Tesla Magnetic Resonance-Guided Prostate Biopsy in Men With Increased Prostate-Specific Antigen and Repeated, Negative, Random, Systematic, Transrectal Ultrasound Biopsies: Detection of Clinically Significant Prostate Cancers
Caroline M. A. Hoeks et al.
EUROPEAN UROLOGY (2012)
Infectious Complications and Hospital Admissions After Prostate Biopsy in a European Randomized Trial
Stacy Loeb et al.
EUROPEAN UROLOGY (2012)
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores
Alberto Briganti et al.
EUROPEAN UROLOGY (2012)
CONCURRENT ANDROGEN DEPRIVATION THERAPY DURING SALVAGE PROSTATE RADIOTHERAPY IMPROVES TREATMENT OUTCOMES IN HIGH-RISK PATIENTS
Daniel E. Soto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Population screening for prostate cancer: An overview of available studies and meta-analysis
Nicolaas Lumen et al.
INTERNATIONAL JOURNAL OF UROLOGY (2012)
Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer
Marie L. Huber et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
Gerald L. Andriole et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
The FinnProstate Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer
Arto J. Salonen et al.
JOURNAL OF UROLOGY (2012)
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial
Matthew R. Smith et al.
LANCET (2012)
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial
David Dearnaley et al.
LANCET ONCOLOGY (2012)
Prostate-Cancer Mortality at 11 Years of Follow-up
Fritz H. Schroder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
Juanita M. Crook et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Radical Prostatectomy versus Observation for Localized Prostate Cancer
Timothy J. Wilt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Salvage radiotherapy after prostatectomy - What is the best time to treat?
Alessandra Siegmann et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group
Donna P. Ankerst et al.
WORLD JOURNAL OF UROLOGY (2012)
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group
Monique J. Roobol et al.
WORLD JOURNAL OF UROLOGY (2012)
Clinical Results after High-Dose Intensity-Modulated Radiotherapy for High-Risk Prostate Cancer
Valerie Fonteyne et al.
ADVANCES IN UROLOGY (2012)
Screening for Prostate Cancer: A Review of the Evidence for the US Preventive Services Task Force
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2011)
Fourteen years of evolution of ESMO Guidelines: from the minimum recommendations to the Consensus Conference-derived guidelines
N. Pavlidis et al.
ANNALS OF ONCOLOGY (2011)
Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching
Ahmed Magheli et al.
BJU INTERNATIONAL (2011)
The influence of family history on prostate cancer risk: implications for clinical management
Stephan Madersbacher et al.
BJU INTERNATIONAL (2011)
Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer
Sameer A. Siddiqui et al.
BJU INTERNATIONAL (2011)
Phase II Study of Abiraterone Acetate in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Displaying Bone Flare Discordant with Serologic Response
Charles J. Ryan et al.
CLINICAL CANCER RESEARCH (2011)
High-Dose Salvage Intensity-Modulated Radiotherapy With or Without Androgen Deprivation After Radical Prostatectomy for Rising or Persisting Prostate-Specific Antigen: 5-Year Results
Piet Ost et al.
EUROPEAN UROLOGY (2011)
Prostate Cancer Biomarkers to Improve Risk Stratification: Is Our Knowledge of Prostate Cancer Sufficient to Spare Prostate Biopsies Safely?
Monique J. Roobol
EUROPEAN UROLOGY (2011)
Advances in Magnetic Resonance Imaging: How They Are Changing the Management of Prostate Cancer
Alessandro Sciarra et al.
EUROPEAN UROLOGY (2011)
Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer: A Multi-institutional Collaboration
Daher C. Chade et al.
EUROPEAN UROLOGY (2011)
Prospective Evaluation of 11C-Choline Positron Emission Tomography/Computed Tomography and Diffusion-Weighted Magnetic Resonance Imaging for the Nodal Staging of Prostate Cancer with a High Risk of Lymph Node Metastases
Tom Budiharto et al.
EUROPEAN UROLOGY (2011)
Combination of Adjuvant Hormonal and Radiation Therapy Significantly Prolongs Survival of Patients With pT2-4 pN+ Prostate Cancer: Results of a Matched Analysis
Alberto Briganti et al.
EUROPEAN UROLOGY (2011)
Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting
Louise Dickinson et al.
EUROPEAN UROLOGY (2011)
DOSE ESCALATION AND QUALITY OF LIFE IN PATIENTS WITH LOCALIZED PROSTATE CANCER TREATED WITH RADIOTHERAPY: LONG-TERM RESULTS OF THE DUTCH RANDOMIZED DOSE-ESCALATION TRIAL (CKTO 96-10 TRIAL)
Abrahim Al-Mamgani et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Androgen Deprivation Therapy and Cardiovascular Risk
Sanoj Punnen et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Cardiovascular Toxicity of Androgen Deprivation Therapy: A New Door Opens
Shabbir M. H. Alibhai
JOURNAL OF CLINICAL ONCOLOGY (2011)
Active Surveillance for Prostate Cancer: Progress and Promise
Matthew R. Cooperberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection
Andrew J. Vickers et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial
Padraig Warde et al.
LANCET (2011)
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Karim Fizazi et al.
LANCET (2011)
Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial
Eva Johansson et al.
LANCET ONCOLOGY (2011)
One Man at a Time - Resolving the PSA Controversy
Mary F. McNaughton-Collins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Anna Bill-Axelson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Dose Escalation for Patients with Decreasing PSA during Radiotherapy for Elevated PSA after Radical Prostatectomy Improves Biochemical Progression-Free Survival Results of a Retrospective Study
Alessandra Siegmann et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2011)
Randomised prostate cancer screening trial: 20 year follow-up
Gabriel Sandblom et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
The Gleason Score of Tumor at the Margin in Radical Prostatectomy is Predictive of Biochemical Recurrence
Dengfeng Cao et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Horwich et al.
ANNALS OF ONCOLOGY (2010)
Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study
Jean-Christophe Eymard et al.
BJU INTERNATIONAL (2010)
Antiandrogen monotherapy in patients with localized or locally advanced prostate cancer: final results from the bicalutamide Early Prostate Cancer programme at a median follow-up of 9.7 years
Peter Iversen et al.
BJU INTERNATIONAL (2010)
Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT
Israel Deutsch et al.
BRACHYTHERAPY (2010)
Introducing the 2010 American Cancer Society Prostate Cancer Screening Guideline
Otis W. Brawley et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
The interval from the last cycle of docetaxel-based chemotherapy to progression is associated with the efficacy of subsequent docetaxel in patients with prostate cancer
Yohann Loriot et al.
EUROPEAN JOURNAL OF CANCER (2010)
Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies
J. A. Lane et al.
EUROPEAN JOURNAL OF CANCER (2010)
Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
Prognostic Parameters, Complications, and Oncologic and Functional Outcome of Salvage Radical Prostatectomy for Locally Recurrent Prostate Cancer after 21st-Century Radiotherapy
Axel Heidenreich et al.
EUROPEAN UROLOGY (2010)
Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
Per-Anders Abrahamsson
EUROPEAN UROLOGY (2010)
Survival Benefit of Radical Prostatectomy in Lymph Node-Positive Patients with Prostate Cancer
Jutta Engel et al.
EUROPEAN UROLOGY (2010)
A Risk-Based Strategy Improves Prostate-Specific Antigen-Driven Detection of Prostate Cancer
Monique J. Roobol et al.
EUROPEAN UROLOGY (2010)
LONG-TERM TOXICITY FOLLOWING 3D CONFORMAL RADIATION THERAPY FOR PROSTATE CANCER FROM THE RTOG 9406 PHASE I/II DOSE ESCALATION STUDY
Jeff M. Michalski et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
SALVAGE RADIOTHERAPY FOR RISING PROSTATE-SPECIFIC ANTIGEN LEVELS AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER: DOSE-RESPONSE ANALYSIS
Johnny Ray Bernard et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Phase I Clinical Trial of the CYP17 Inhibitor Abiraterone Acetate Demonstrating Clinical Activity in Patients With Castration-Resistant Prostate Cancer Who Received Prior Ketoconazole Therapy
Charles J. Ryan et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09
Anthony L. Zietman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian de Bono et al.
LANCET (2010)
Mortality results from the Goteborg randomised population-based prostate-cancer screening trial
Jonas Hugosson et al.
LANCET ONCOLOGY (2010)
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
Michel Bolla et al.
LANCET ONCOLOGY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Long-Term Outcome of Patients with High-Risk Prostate Cancer following Radical Prostatectomy and Stage-Dependent Adjuvant Androgen Deprivation
Martin Spahn et al.
UROLOGIA INTERNATIONALIS (2010)
Tumor Grade at Margins of Resection in Radical Prostatectomy Specimens Is an Independent Predictor of Prognosis
Fadi Brimo et al.
UROLOGY (2010)
Prostate-specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling time
Michael K. Ng et al.
BJU INTERNATIONAL (2009)
Radical prostatectomy for prostatic adenocarcinoma: a matched comparison of open retropubic and robot-assisted techniques
Amy E. Krambeck et al.
BJU INTERNATIONAL (2009)
Radiation Dose Escalation for Localized Prostate Cancer Intensity-Modulated Radiotherapy Versus Permanent Transperineal Brachytherapy
William W. Wong et al.
CANCER (2009)
Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: A systematic review and meta-analysis of randomised trials
M. D. Shelley et al.
CANCER TREATMENT REVIEWS (2009)
Digital Rectal Examination and the Diagnosis of Prostate Cancer-a Study Based on 8 Years and Three Screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam
Claartje Gosselaar et al.
EUROPEAN UROLOGY (2009)
European Association of Urology Position Statement on Screening for Prostate Cancer
Per-Anders Abrahamsson et al.
EUROPEAN UROLOGY (2009)
Early Versus Delayed Endocrine Treatment of T2-T3 pN1-3 M0 Prostate Cancer Without Local Treatment of the Primary Tumour: Final Results of European Organisation for the Research and Treatment of Cancer Protocol 30846 After 13 Years of Follow-up (A Randomised Controlled Trial)
Fritz H. Schroder et al.
EUROPEAN UROLOGY (2009)
Outcomes of Men with Screen-Detected Prostate Cancer Eligible for Active Surveillance Who Were Managed Expectantly
Roderick C. N. van den Bergh et al.
EUROPEAN UROLOGY (2009)
Intermittent Androgen Deprivation for Locally Advanced and Metastatic Prostate Cancer: Results from a Randomised Phase 3 Study of the South European Uroncological Group
Fernando E. C. Calais da Silva et al.
EUROPEAN UROLOGY (2009)
Long-Term Follow-up of Patients with Prostate Cancer and Nodal Metastases Treated by Pelvic Lymphadenectomy and Radical Prostatectomy: The Positive Impact of Adjuvant Radiotherapy
Luigi F. Da Pozzo et al.
EUROPEAN UROLOGY (2009)
Androgen Deprivation Therapy for the Treatment of Prostate Cancer: Consider Both Benefits and Risks
Hendrik Isbarn et al.
EUROPEAN UROLOGY (2009)
EFFICACY OF SALVAGE RADIOTHERAPY PLUS 2-YEAR ANDROGEN SUPPRESSION FOR POSTRADICAL PROSTATECTOMY PATIENTS WITH PSA RELAPSE
Richard Choo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
ACHIEVING AN UNDETECTABLE PSA AFTER RADIOTHERAPY FOR BIOCHEMICAL PROGRESSION AFTER RADICAL PROSTATECTOMY IS AN INDEPENDENT PREDICTOR OF BIOCHEMICAL OUTCOME-RESULTS OF A RETROSPECTIVE STUDY
Thomas Wiegel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
HIGHER-THAN-CONVENTIONAL RADIATION DOSES IN LOCALIZED PROSTATE CANCER TREATMENT: A META-ANALYSIS OF RANDOMIZED, CONTROLLED TRIALS
Gustavo Arruda Viani et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
NEED FOR HIGH RADIATION DOSE (≥70 GY) IN EARLY POSTOPERATIVE IRRADIATION AFTER RADICAL PROSTATECTOMY: A SINGLE-INSTITUTION ANALYSIS OF 334 HIGH-RISK, NODE-NEGATIVE PATIENTS
Cesare Cozzarini et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Comparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy
Jim C. Hu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous Bisphosphonates
Karim Fizazi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95
Thomas Wiegel et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
15-Year Followup of a Population Based Prostate Cancer Screening Study
Anders Kiellman et al.
JOURNAL OF UROLOGY (2009)
Location, Extent and Number of Positive Surgical Margins Do Not Improve Accuracy of Predicting Prostate Cancer Recurrence After Radical Prostatectomy
Andrew J. Stephenson et al.
JOURNAL OF UROLOGY (2009)
Prostate Specific Antigen Best Practice Statement: 2009 Update
Kirsten L. Greene et al.
JOURNAL OF UROLOGY (2009)
Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
Ian M. Thompson et al.
JOURNAL OF UROLOGY (2009)
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
Anders Widmark et al.
LANCET (2009)
Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials
David P. Dearnaley et al.
LANCET ONCOLOGY (2009)
Prostate kallikrein markers in diagnosis, risk stratification and prognosis
David Ulmert et al.
NATURE REVIEWS UROLOGY (2009)
Duration of Androgen Suppression in the Treatment of Prostate Cancer
Michel Bolla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa
D. R. Berthold et al.
ANNALS OF ONCOLOGY (2008)
The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
Laurence Klotz et al.
BJU INTERNATIONAL (2008)
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden
Andrew J. Vickers et al.
BMC MEDICINE (2008)
Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer - Results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel
Tomasz M. Beer et al.
CANCER (2008)
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer:: a meta-analysis
A. M. Hovels et al.
CLINICAL RADIOLOGY (2008)
Current decision-making in prostate cancer therapy
Jared Cox et al.
CURRENT OPINION IN UROLOGY (2008)
The role of the digital rectal examination in subsequent screening visits in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam
Claartje Gosselaar et al.
EUROPEAN UROLOGY (2008)
An analysis of radical prostatectomy in advanced stage and high-grade prostate cancer
Hendrik Van Poppel et al.
EUROPEAN UROLOGY (2008)
Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891)
Urs E. Studer et al.
EUROPEAN UROLOGY (2008)
Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02
Jason A. Efstathiou et al.
EUROPEAN UROLOGY (2008)
The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone:: A systematic review
Fritz Schroder et al.
EUROPEAN UROLOGY (2008)
Improved outcomes with higher doses for salvage radiotherapy after prostatectomy
Christopher R. King et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Radiotherapy after prostatectomy: Is the evidence for dose escalation out there?
Christopher R. King et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Long-term results of conformal radiotherapy for prostate cancer: Impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes
Michael J. Zelefsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
Deborah A. Kuban et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy
Bruce J. Trock et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survival in the TAX 327 study
Dominik R. Berthold et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven
Gerhardt Attard et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Ten-year follow-up of radiation therapy oncology group protocol 92-02: A phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer
Eric M. Horwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006
Michael Musch et al.
JOURNAL OF UROLOGY (2008)
Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: A matched cohort study
Sameer A. Siddiqui et al.
JOURNAL OF UROLOGY (2008)
A Graphical Device to Represent the Outcomes of a Logistic Regression Analysis
Ries Kranse et al.
PROSTATE (2008)
Endorectal magnetic resonance imaging staging of prostate cancer
Ronil V. Chandra et al.
ANZ JOURNAL OF SURGERY (2007)
Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy:: EORTC 22911
Theodorus H. Van der Kwast et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study
Sigrid Carlsson et al.
EUROPEAN JOURNAL OF CANCER (2007)
Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer:: Diagnostic and cost-effectiveness and comparison with current detection strategies
Frederic E. Lecouvet et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial
Peter J. Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): A new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy
Chris Parker et al.
BJU INTERNATIONAL (2007)
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin tables) based on cases from 2000 to 2005
Danil V. Makarov et al.
UROLOGY (2007)
Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial
David P. Dearnaley et al.
LANCET ONCOLOGY (2007)
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Andrew J. Stephenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Death in patients with recurrent prostate cancer after radical prostatectomy: Prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality
Stephen J. Freedland et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation
Michael J. Zelefsky et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Outcome of surgery for clinical unilateral T3a prostate cancer: A single-institution experience
Chao-Yu Hsu et al.
EUROPEAN UROLOGY (2007)
Prediction of indolent prostate cancer: Validation and updating of a prognostic nomogram
E. W. Steyerberg et al.
JOURNAL OF UROLOGY (2007)
Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy
Milena Braga-Basaria et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer
Brett S. Carver et al.
JOURNAL OF UROLOGY (2006)
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
Eric J. Small et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer
Sue A. Joslyn et al.
UROLOGY (2006)
Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: A prospective analysis
Ryan K. Berglund et al.
UROLOGY (2006)
Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy
Edward M. Messing et al.
LANCET ONCOLOGY (2006)
Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy
STH Peeters et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European organisation for research and treatment of cancer (EORTC) trial 30891
UE Studer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Assessing prostate cancer risk: Results from the prostate cancer prevention trial
IM Thompson et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer
TA Masterson et al.
JOURNAL OF UROLOGY (2006)
Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer
MR Smith et al.
JOURNAL OF UROLOGY (2006)
Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy
SF Slovin et al.
CLINICAL CANCER RESEARCH (2005)
Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate - A randomized controlled trial
AL Zietman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Postoperative radiotherapy after radical prostatectomy:: a randomised controlled trial (EORTC trial 22911)
M Bolla et al.
LANCET (2005)
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
SJ Freedland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer
MR Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome
JF Ward et al.
BJU INTERNATIONAL (2005)
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma - Long-term results of Phase III RTOG 85-31
MV Pilepich et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer
MR Smith
UROLOGY (2004)
Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma
J Hugosson et al.
CANCER (2004)
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy
JW Moul et al.
JOURNAL OF UROLOGY (2004)
Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer
F Saad et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Fetoscopic placement of a transurethral stent for intrauterine obstructive uropathy
R Hofmann et al.
JOURNAL OF UROLOGY (2004)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter
IM Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Screening decreases prostate cancer mortality:: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial
F Labrie et al.
PROSTATE (2004)
Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: Do outcomes differ?
OK MacDonald et al.
UROLOGY (2004)
Superior anti-tumor efficacy of bicalutamide 80 mg in combination with a luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist monotherapy as first-line treatment for advanced prostate cancer: Interim results of a randomized study in Japanese patients
H Akaza et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2004)
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer
I Cagiannos et al.
JOURNAL OF UROLOGY (2003)
Lead times and overdetection due to prostate-specific antigen screening:: Estimates from the European randomized study of screening for prostate cancer
G Draisma et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: The Radiation Therapy Oncology Group Protocol 92-02
GE Hanks et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer
T Clark et al.
JOURNAL OF UROLOGY (2003)
Prostate cancer: radical prostatectomy
JB Nelson et al.
UROLOGIC CLINICS OF NORTH AMERICA (2003)
Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma - Impact on changing treatment modalities
A Haese et al.
CANCER (2002)
Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial
A Pollack et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Radical radiation for localized prostate cancer: Local persistence of disease results in a late wave of metastases
JJ Coen et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
M Bolla et al.
LANCET (2002)
Family history and prostate cancer screening with prostate-specific antigen
T Mäkinen et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: High incidence of lymph node metastasis
A Heidenreich et al.
JOURNAL OF UROLOGY (2002)
Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer
RM Galalae et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium
AW Partin et al.
UROLOGY (2001)
Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy - The 15-year Johns Hopkins experience
M Han et al.
UROLOGIC CLINICS OF NORTH AMERICA (2001)
Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients
CA Dykewicz
CLINICAL INFECTIOUS DISEASES (2001)
Prostate specific antigen only progression of prostate cancer
JW Moul
JOURNAL OF UROLOGY (2000)
分享论文
